Topic: How To Invest

Wall Street Stock Forecaster Hotline – Friday, February 11, 2022

Article Excerpt

PFIZER INC., $50.78, New York symbol PFE, is your #1 Income Buy for 2022. The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex and Enbrel (arthritis), and Prevnar (pneumonia). Pfizer has increased its dividend rate each year since 2011. Starting with the March 2022 payment, the company will raise your quarterly dividend by 2.6%. Investors will then receive $0.40 a share instead of $0.39. The new annual rate of $1.60 yields a solid 3.2%. Sales in the three months ended December 31, 2021, jumped 104.9%, to $23.84 billion from $11.63 billion a year earlier. That gain is mainly due to strong demand for the company’s two-shot COVID-19 vaccine (formally called Comirnaty), which it developed in partnership with German drugmaker BioNTech (Nasdaq symbol BNTX). Comirnaty sales totalled $12.5 billion in the latest quarter, or 52% of the total. Pfizer is also seeing strong demand for its new COVID-19 pill (called Paxlovid), which received regulatory approval in…